Happy new year - may 2023 bring the Xmas present that we all...

Happy new year - may 2023 bring the Xmas present that we all been waiting for - Ryoncil Approval

It's the first day of the new year, and I'm just sitting here reflecting on MSB.
I'm still a MSB believer and have not sold one MSB share!

To be frank, if I've known what I know now, I would have sold out of MSB and got back in at these ridiculous low SP levels.
It has been an arduous long road, and the last two CRL years have stretched it out even further.
I feel like I was a greenhorn as I didn't fully understand the FDA approval process and did not have a good grasp on the CRL either...
But, all that is in the past.

2023 got to be the year for Ryoncil approval.
Mesoblast have dotted the i's and crossed the t's - there's no more to be done!
The submission is due and at this stage we are still awaiting for Ryoncil approval in H1 2023.

Sure, there are other bigger indications that MSB have been working on.
But, IMO it's Ryoncil approval or bust!

Mesoblast has been focussed on Ryoncil, if they can't get Ryoncil pass the FDA line with so much time and energy spent on it - the market will react accordingly.
I don't really want to consider this prospect, but it is a risk - as the FDA are a law unto themselves.

So my only focus on MSB at the moment is that 2023 got to be the year for Ryoncil approval.
All the news on other indications is pretty much secondary to me.

Things with the FDA may take a bit longer than expected, but we'll see the wheels in motion and assess Ryoncil progress once the BLA has been resubmitted - bring it on!

Let's get to the last part, the enjoyable part, of this road to commercialisation

GL MSB'ers - may 2023 bring happiness, health and a prosperous to all MSB'ers